drugset
drugset / Trial / NCT04611373

Clinical Study on the Efficacy of Acetazolamide Combined With Levamisole in the Treatment of HCC

NCT04611373 ↗

Phase 3 Unknown 50 enrolled The First Affiliated Hospital of Zhengzhou University
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of acetazolamide combined with levamisole in the treatment of advanced HCC.

Timeline

Start
2020-05-01
Primary completion
2020-12-01
Completion
2021-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetazolamide Small molecule 50 mg —
Subject Levamisole Small molecule 150 mg —

Indications

hepatocellular carcinoma